We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Goosehead Insurance
GSHD
$2.38B
| $575K | ﹤0.01% |
13,556
+248
| +2% | +$11K |
|
2302
Antero Resources
AR
$10.6B
| $573K | ﹤0.01% |
200,890
+2,171
| +1% | +$5.54K |
|
2303
Bally's
BALY
$686M
| $573K | ﹤0.01% |
22,347
-403
| -2% | -$9.71K |
|
2304
Ring Energy
REI
$312M
| $571K | ﹤0.01% |
216,354
+14,437
| +7% | +$28.3K |
|
2305
Sterling Infrastructure
STRL
$16.4B
| $570K | ﹤0.01% |
40,460
+393
| +1% | +$5.92K |
|
2306
Civista Bancshares
CIVB
$600M
| $569K | ﹤0.01% |
23,702
+42
| +0.2% | +$932 |
|
|
AGEN
2307
Agenus
AGEN
$324M
| $568K | ﹤0.01% |
7,106
+46
| +0.7% | +$3.09K |
|
2308
Alector
ALEC
$165M
| $568K | ﹤0.01% |
32,937
+1,108
| +3% | +$18.8K |
|
|
GLOG
2309
DELISTED
GASLOG LTD
GLOG
| $563K | ﹤0.01% |
57,468
-1,610
| -3% | -$18.3K |
|
2310
Barnes & Noble Education
BNED
$439M
| $562K | ﹤0.01% |
1,316
+63
| +5% | +$25.9K |
|
|
MOBL
2311
DELISTED
MobileIron, Inc.
MOBL
| $562K | ﹤0.01% |
115,586
+1,807
| +2% | +$9.63K |
|
2312
Anterix
ATEX
$1.94B
| $559K | ﹤0.01% |
12,943
+445
| +4% | +$18.1K |
|
2313
Ardelyx
ARDX
$1.21B
| $557K | ﹤0.01% |
74,222
+983
| +1% | +$5.97K |
|
2314
FRP Holdings
FRPH
$420M
| $555K | ﹤0.01% |
22,266
+8
| +0% | +$201 |
|
|
ANH
2315
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $555K | ﹤0.01% |
157,745
-580
| -0.4% | -$2.01K |
|
|
SRNE
2316
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $554K | ﹤0.01% |
163,774
+6,998
| +4% | +$16.7K |
|
2317
KKR & Co
KKR
$94.9B
| $550K | ﹤0.01% |
18,860
+260
| +1% | +$7.41K |
|
2318
Amerant Bancorp
AMTB
$1.16B
| $549K | ﹤0.01% |
25,195
+848
| +3% | +$17.6K |
|
2319
Liquidity Services
LQDT
$1.17B
| $548K | ﹤0.01% |
91,967
+4,698
| +5% | +$30.2K |
|
|
GTT
2320
DELISTED
GTT Communications, Inc.
GTT
| $548K | ﹤0.01% |
48,260
+242
| +0.5% | +$2.02K |
|
|
ORC
2321
Orchid Island Capital
ORC
$1.28B
| $547K | ﹤0.01% |
18,703
+595
| +3% | +$17.1K |
|
2322
Impinj
PI
$4.99B
| $547K | ﹤0.01% |
21,154
+797
| +4% | +$24.8K |
|
2323
Citizens & Northern Corp
CZNC
$453M
| $546K | ﹤0.01% |
19,345
-176
| -0.9% | -$4.58K |
|
2324
Surgery Partners
SGRY
$2B
| $545K | ﹤0.01% |
34,804
+402
| +1% | +$4.56K |
|
|
CDMO
2325
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $545K | ﹤0.01% |
71,001
+313
| +0.4% | +$1.83K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.